MAPT and Alzheimer disease: Morin is a GSK‐3β inhibitor that reduces tau pathology in vivo and in vitro, and morin inhibits GSK‐3β by binding to the ATP‐binding pocket, suggesting that morin may serve as a functional food for AD treatment.157